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Measurement of the activity of human pluripotent stem cell (hPSC)-derived neuronal
networks with microelectrode arrays (MEAs) plays an important role in functional in
vitro brain modelling and in neurotoxicological screening. The previously reported
hPSC-derived neuronal networks do not, however, exhibit repeatable, stable functional
network characteristics similar to rodent cortical cultures, making the interpretation of
results difficult. In earlier studies, microtunnels have been used both to control and guide
cell growth and amplify the axonal signals of rodent neurons. The aim of the current study
was to develop tunnel devices that would facilitate signalling and/or signal detection
in entire hPSC-derived neuronal networks containing not only axons, but also somata
and dendrites. Therefore, MEA-compatible polydimethylsiloxane (PDMS) tunnel devices
with 8 different dimensions were created. The hPSC-derived neurons were cultured in
the tunnel devices on MEAs, and the spontaneous electrical activity of the networks
was measured for 5 weeks. Although the tunnel devices improved the signal-to-noise
ratio only by 1.3-fold at best, they significantly increased the percentage of electrodes
detecting neuronal activity (52–100%) compared with the controls (27%). Significantly
higher spike and burst counts were also obtained using the tunnel devices. Neuronal
networks inside the tunnels were amenable to pharmacological manipulation. The results
suggest that tunnel devices encompassing the entire neuronal network can increase the
measured spontaneous activity in hPSC-derived neuronal networks on MEAs. Therefore,
they can increase the efficiency of functional studies of hPSC-derived networks onMEAs.
Keywords: human pluripotent stem cells, microelectrode array, neuronal network, tunnel device, in vitro model
INTRODUCTION
Analysis of neuronal network activity in vitro is a pivotal part of modern brain disease modelling,
neuropharmacological testing, and neurotoxicological screening (Johnstone et al., 2010; Valdivia
et al., 2014). In vitro neuronal networks derived from human pluripotent stem cells (hPSCs)
can replace animal-derived models and better predict responses in humans (Cavanaugh et al.,
2014; Hunsberger et al., 2015; Pei et al., 2016). Furthermore, their activity can be measured using
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microelectrode arrays (MEAs) (Johnstone et al., 2010; Jones et al.,
2011; Moser, 2011). For example, the effect of a neurotoxin on
the MEA-activity of a hPSC-derived network can be observed
before any morphological changes (Ylä-Outinen et al., 2010).
However, analyses of MEA data from hPSC-derived networks
can be very challenging due to low percentage of electrodes
(often <20%), or entire arrays, that detect neuronal activity
(Ylä-Outinen et al., 2010; Tukker et al., 2016). Even when the
hPSC-derived networks produce robust, measurable activity, the
necessary differentiation and functional development can be very
slow, taking up to several months (Odawara et al., 2016). The
variable and slow development of neuronal network activity on
MEA appears to be characteristic to all neuronal cultures of
human origin; in primary human neurons, which do not require
pre-differentiation, the emergence of electrical activity can take
nearly 40 days, where as in corresponding rat neurons the
same development happens in only 10 days (Napoli and Obeid,
2016). Therefore, it is clear that new approaches are needed
to facilitate the analysis of hPSC-derived neuronal network
functions.
Microengineered polydimethylsiloxane (PDMS) devices can
be used to answer specific questions on mechanisms of neural
function and pathology (Taylor et al., 2005; Scott et al., 2013; Ren
et al., 2015), and they can also be used to facilitate the analysis
of electrical function of hPSC-derived networks. PDMS devices
consisting an open chamber (or “well”) can guide the network
to grow more densely on top of the measuring electrodes, and
thus facilitate the development and detection of neuronal activity
(Kreutzer et al., 2012). PDMS microtunnel devices, on the other
hand, increase the detected activity by amplifying extracellular
electrical signals detected by the MEA (FitzGerald et al., 2009;
Wieringa et al., 2010; Wang et al., 2012). According to a generally
accepted theory in the field this occurs because signal amplitudes
measured by MEA in tunnels are influenced by a derivative
of Ohm’s law (U = R I), where the resistance of the medium
inside the tunnel increases as the tunnels height (h) and width
(w), i.e., cross section (A) decreases and length (l) increases
(R = ρ (l / A)). The increased resistance, in turn, manifests
as higher potential differences during electrical activity of the
measured cells, which translates to an increased signal-to-noise
ratio (SNR) in the MEA recordings. However, the microtunnels
providing the best amplification (cross sections ≤100 µm2, h
≤ 5µm) are designed to encompass only neurites and not
neuronal somata or entire neuronal networks, and often require a
custommade electrode array (FitzGerald et al., 2008; Dworak and
Wheeler, 2009; Hong et al., 2017). These neurite-encompassing
microtunnels are useful for analysing certain parameters such as
the speed of signal conduction along axons, but there is a need
for larger tunnel devices which can provide robust MEA data
from entire neuronal networks containing also dendrites and
cell somata.
In this study, the objective was to develop tunnel devices
that are compatible with a commercially available MEA
platform, and are able to house entire hPSC-derived neuronal
networks and concomitantly possess sufficiently small features
to amplify the extracellular signals on MEAs in comparison to
standard cultures. Therefore, hPSC-derived neuronal networks
were cultured on MEAs in tunnel devices with different
dimensions. The spontaneous electrical activity of the neuronal
networks in the tunnels was measured up to 5 weeks and
compared to data from standard MEA controls. We observed
that while the tunnels provided little or no improvement
of signal detection, they increased the measured network
activity considerably. Thus, the use of the tunnel devices
solved one of the main problems in studying hPSC-derived
networks using MEAs, which is the low percentage of active
electrodes.
MATERIALS AND METHODS
Production of MEA-Compatible PDMS
Tunnel Devices
Custom PDMS tunnel devices and SU-8 moulds for the
devices were fabricated using rapid prototyping methods
(Duffy et al., 1998). The outer diameter of the PDMS
devices (Figure 1A) was 15mm and the height was
approximately 3mm to be compatible with the MEA array
(60MEA200/30iR-Ti MEAs, MultiChannelSystem [MCS],
Germany) and amplifier (MEA2100, MCS). The PDMS devices
contained two cell plating areas that were interconnected
by tunnels and a reference electrode well. The designed
tunnel dimensions were varied as presented in Table 1 and
Figure 1. The cell cultivation area in front of the tunnels
is covered by a PDMS lid. The different PDMS tunnels
were aligned on top of the MEA electrodes as illustrated in
Figures 1B–F.
PDMS (Sylgard 184, Dow Corning) devices were fabricated
using methods described by Park et al. (2006). The moulds were
fabricated from SU-8 3050 (Micro Resist Technology GmbH)
on top of a silicon wafer. A 15-mm-diameter punching tool
was used to punch individual devices out of PDMS sheets.
A 3-mm-diameter manual punching tool was used to create
inlets (cell plating areas; Figure 1A) at a distance of 100–
1,000µm from the tunnel mouth, and an opening for the
reference electrode. The use of circular cell supply inlets and
the need to have equal tunnel lengths created a lid around
the punching hole. Thus, the MEA electrodes placed in front
of the tunnels were covered by the PDMS lid located either
43 or 105µm above the MEA surface depending on the
tunnel height. Hereafter, these electrodes located underneath
the PDMS lid but outside the tunnels are referred as outside
electrodes.
The dimensions of the tunnel devices were characterised
using both light microscopy and profilometry. A Zeiss Axio
Imager.A1m (Carl Zeiss AG) was used to inspect the mould
for potential faults. A Bruker Dektak XT stylus profilometer
(Bruker Corporation) was used to measure the heights
of the microstructures from the mould. According to the
measurements, the mould heights were 43 ± 7µm and 105 ±
15µm. The variation in heights was caused by the slight bending
of the silicon wafers by the spinner vacuum during spin-coating,
which caused the features to be thicker in the middle of the
moulds.
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TABLE 1 | Tunnel dimensions and number of tunnels, electrodes and MEAs.




area or MEA well
Total n of analysed





Total n of active electrodes per week
1 2 3 4 5
6-well MEA control 5\– 9 30\–\– 270\– 75 107 120 146 101
1-well MEA control 4\– 59 4\–\– 236\– – 1 18 39 42
Outside 43 – 13\8 12 13\8\– 156\96 29 87 112 119 118
Outside 105 – 21\15 12 21\15\– 254\180 9 74 150 157 154
100 43 1,000 5\4 4 6\4\5 24\16 13 18 24 24 24
100 105 1,000 7\5 4 9\5\7 36\20 2 14 24 34 31
500 43 1,000 1\– 11–12 2\–\2 23\– 3 2 12 21 23
500 105 1,000 2\– 11–12 4\–\3 46\– 1 6 34 40 44
750 43 1,000 3\2 15–16 4\2\2 63/32 8 24 40 47 48
750 105 1,000 7\5 15–16 9\5\6 142/80 7 48 71 92 91
1,500 43 1,000 5\2 31 5\2\4 155/62 11 69 127 131 127
1,500 105 1,000 7\5 31 7\5\3 217\155 4 39 167 111 137
The tunnel width (w), height (h) and length (l) are presented in the first three columns. “Outside” refers to electrodes outside the actual tunnels but underneath the PDMS lid (Figure 1).
The second number after the backslash indicates the corresponding number in the pharmacological experiment (Figure 6), and the third number after the second backslash indicates
n in the CytoSpectre network orientation analysis (Figure 3E).
Preparation of PDMS Tunnel Devices and
MEAs for Cell Culture
The MEAs were always cleaned before use according to
manufacturer’s instructions (washed with 1% Tergazyme [Sigma-
Aldrich], rinsed with distilled H2O and autoclaved). MEAs were
coated with 0.05% polyethylenimine as previously described
(Ylä-Outinen et al., 2010). To make the tunnels hydrophilic and
thus amenable to coating, the PDMS devices were treated with
oxygen plasma in a PICO plasma system (Diener electronic) for
3min at 50W. They were manually aligned under a microscope
on the MEA electrodes and reversibly bonded to the MEAs, i.e.,
they could still be manually removed. Mouse laminin (20µg/ml;
Sigma-Aldrich) was pipetted into the PDMS tunnel devices on
MEAs through both cell plating areas (Figure 1A). Cell culture
control plates (4-well plate, Nunc, Thermo Fisher Scientific, Inc.)
were coated with 20µg/ml or 10µg/ml mouse laminin in wells
with or without coverslips (Ø = 13mm, VWR), respectively.
The MEAs and the control plates were incubated with the
laminin solutions at +4◦C overnight as previously described
(Ylä-Outinen et al., 2010).
Neural Differentiation and Cell Culture
The human embryonic stem cell (hESC) line Regea 08/023
and the human induced pluripotent stem cell (hiPSC) line
04311.WT were used in the experiments. BioMediTech has
approval from the Finnish Medicines Agency (FIMEA) to
perform research with human embryos (Dnro 1426/32/300/05).
There are also supportive statements from the regional
ethical committee of Pirkanmaa Hospital District for the
derivation, culturing, and differentiation of hESCs (R05116) and
hiPSCs (R08070). This study was carried out in accordance
with the recommendations of FIMEA and Pirkanmaa
Hospital District with written informed consent from all
subjects who provided cell material. All subjects gave written
informed consent in accordance with the Declaration of
Helsinki.
The timeline for the experiments is shown in Figure 2.
The hESCs and hiPSCs were differentiated into neural cells
for 8–10 weeks in neurosphere cultures in differentiation
medium (NDM) consisting of 1:1 Dulbecco’s Modified Eagle’s
Medium/F12:Neurobasal Medium supplemented with 2mM
GlutaMax, 1x B27 supplement, 1x N2 supplement (all from
Gibco Invitrogen), 25 U/ml penicillin/streptomycin (Lonza
Group Ltd) and, in this neurosphere differentiation stage,
20 ng/ml basic fibroblast growth factor (bFGF, R&D Systems)
as previously described (Lappalainen et al., 2010) with or
without low-dose naltrexone LDN193189 (100 nM; Stemcell
Technologies, Inc.).
The neurospheres containing pre-differentiated neural cells
were manually dissected into small cell aggregates (Ø∼50–
200µm). Approximately 15 small aggregates (50,000–150,000
cells in total) were plated in both cell plating areas of the PDMS
devices (i.e., both ends of the tunnels) as close to the tunnels
as possible to ensure tunnel colonization, and similarly on
control plate wells. The plating procedure was identical for each
device. The PDMS devices on the MEAs were submerged in
the cell culture medium (1ml). The cells were maintained in a
humidified incubator at 37◦C and 5% CO2. Half of the medium
was changed three times a week. After 1 week in adherent
culture, 4 ng/ml bFGF and 5 ng/ml brain-derived neurotrophic
factor (BDNF) (Gibco Invitrogen) were added to the
medium.
Immunocytochemistry
The control cells were fixed after 14 days in adherent culture,
and immunocytochemical (ICC) staining was performed
as previously described (Lappalainen et al., 2010) to verify
the neural identity of the cells. Primary antibodies, rabbit
anti-beta-III Tubulin (β-tub) (1:2000; GenScript) and rabbit
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FIGURE 1 | Designs of the tunnel devices. The PDMS tunnel devices (A) consist of two cell plating areas that are interconnected by tunnels, and a reference
electrode well. The two tunnel heights are presented in the lower right corner in (A). The red dashed lines indicate the cross section of a tunnel, in this case 100µm
wide. The numbers in (A) provide the tunnel widths (w) and heights (h) in µm. Tunnels with different dimensions were aligned on MEAs (B–F). Dark gray indicates
PDMS bonded to the MEA surface, light grey represents cell cultivation areas in the tunnels and areas under the PDMS lid, while the red dashed lines indicate tunnel
perimeters. The numbers in (B–F) provide the tunnel widths (w) and lengths (l) in µm.
FIGURE 2 | Timeline of the experiments. Neurons were differentiated in
neurosphere culture for 8–10 weeks before adherent culture in tunnel devices
on MEAs and in standard cell culture wells (control cells). MEA measurements
were performed twice weekly over 5 weeks, and a pharmacological test was
performed at the end of the culture. Neurite orientation analysis was
performed from the phase contrast images taken at the 5th week.
Immunocytochemistry was performed on control cells after 2 weeks in
adherent culture for both cell lines.
polyclonal anti-Microtubule-Associated Protein 2 (MAP2)
(1:400; Millipore), were used together with secondary antibodies,
Alexa 488 anti-rabbit and Alexa 568 anti-mouse (both 1:400;
Molecular Probes). In addition, the nuclei of the cells were
stained with 4′,6-diamidino-2 phenylindole (DAPI), which
was included in the mounting medium (Vectashield Mounting
Medium with DAPI, Vector Laboratories). The cells were imaged
with a fluorescence microscope (Olympus IX51, Olympus
Corporation).
Phase Contrast Microscopy and Neurite
Orientation Analysis
The cells were imaged with a phase contrast microscope
(Nikon Eclipse TE2000-S, Nikon Corporation) once per week
to follow the neuronal morphology, migration and network
formation. The cell culture control plates were used as a normal
microenvironment cell control to evaluate neuronal viability,
morphology and migration. The control plates were followed for
2 weeks.
The orientation of the neurites was analysed using
CytoSpectre 1.2 software (http://www.tut.fi/cytospectre)
Frontiers in Neuroscience | www.frontiersin.org 4 October 2017 | Volume 11 | Article 606
Toivanen et al. PDMS Tunnels Increase MEA Activity
(Kartasalo et al., 2015). The software utilises spectral analysis
and calculates the orientations of image components, in
this case neurites (Hyysalo et al., 2017), and describes their
variance with a circular variance value, which is 1 when the
components are randomly aligned, and 0 when all components
are completely unidirectional. The software was used in the
mixed component mode and spectral resolution/noise was set
to balanced. Wavelength settings (component size) were set to
1µm (minimum) and 30µm (maximum). The orientation of
neurites inside the tunnels was analysed using phase contrast
images obtained at week 5 after plating, and compared to images
of the freely growing networks on cell culture control plates. The
electrodes and their tracks were excluded from the image analysis
by using a custom MATLAB script which automatically detected
the electrodes and the tracks and replaced their pixel values
with local mean intensities computed from the corresponding
regions of each image, and by using CytoSpectre’s component
size filtering.
MEA Measurements
MEA measurements were performed with an MEA system
consisting of a filter amplifier MEA2100, software MC_Rack
and temperature controllers TC02 set at 37◦C (all from MCS).
The electrical activity of the neuronal networks was measured
twice a week for 5 weeks (Figure 2). The duration of each
recording was 10min and the sampling rate was 25 kHz. To
analyse the noise, signal amplitude and SNR in the tunnel devices,
the MEA data were compared to earlier recordings from the
same 60MEA200/30iR-Ti MEAs with no PDMS tunnel devices,
referred to as the 1-well MEA control. The 1-well MEA control
is an open volume system with no liquid volume restrictions.
To analyse the development of network activity, the data were
compared to recordings from 60-6wellMEA200/30iR-Ti MEAs
(MCS), in which the individual wells were separated using
SpikeBooster devices (BioMediTech) (Kreutzer et al., 2012), and
is referred to as the 6-well MEA control. The dimensions of the
cell culturing areas on the SpikeBooster devices are the same
as the cell plating areas on the tunnel devices, and the 6-well
MEA control can be considered a partially restricted volume
system. The combination of 6-well MEAs and SpikeBooster is the
most used MEA setup in our laboratory, and it typically provides
the best network activity development. All used MEAs had the
same surfacematerial (Si3N4), electrodematerial (TiN), electrode
diameter (30µm) and electrode-to-electrode distance (200µm).
Pharmacological testing with tetrodotoxin (TTX; 1µM,
Tocris Bioscience) was performed at the end of the study
(Figure 2). MEA activity was measured for 5min after addition
of fresh medium to the MEA and after addition of TTX to
the medium where the PDMS device was submerged. TTX
and the equipment used for handling it were stored, handled
and disposed according to institutional safety regulations
(BioMediTech institute and Faculty of Medicine and Biosciences,
University of Tampere).
Signal Analysis and Statistics
Spikes were detected from the MEA data using MATLAB (The
MathWorks, Inc.) with a custom-made analysis program based
on Quiroga et al. (2004). Analysis was performed separately
for each electrode (modified from Quiroga et al., 2004). First,
the voltage signal was filtered (200–3,000Hz band pass). Next,
the noise was calculated as the median (md) of the absolute
values from the filtered recording divided by 0.6745. Signal values
which exceeded five times this noise value were considered as
spikes. Both negative and positive spikes were detected. Spikes
larger than 500 times noise were removed as artefacts. For spike
waveform analysis, 0.8 and 1.76ms of voltage signal was clipped
before and after the largest absolute value of the spike from the
filtered data. The detector dead time between two waveforms
was 1.48ms. The peak-to-peak amplitudes were measured as
the difference between the highest and lowest voltage values
in the stored waveforms. A peak-to-peak md was obtained
from all waveforms from one channel to identify a single value
per channel. SNR was calculated by dividing the md peak-
to-peak spike amplitudes by the corresponding noise values.
An electrode was regarded as an active electrode (measuring
neuronal activity) if more than 2 spikes were recorded in aminute
(spike frequency 0.033Hz). The threshold was determined by
measuring the spike rates from empty MEAs and MEAs with
TTX-silenced neuronal cultures (data not shown). Percentage
of active electrodes was calculated for each tunnel and control
well separately and electrodes underneath the PDMS devices
were excluded from the analysis. Data from the electrodes at the
tunnels mouth (under the red dashed line in Figures 1B–F) were
not included in analyses because they could be considered neither
outside nor tunnel electrodes. Bursts (clusters of spikes) were
detected separately for each electrode using a method based on
Kapucu et al. (2012) which defines bursts using the cumulative
moving average of inter-spike intervals.
The number of repeats (n) in different analyses are presented
in Table 1. Statistical analyses were performed in SPSS (IBM).
The MEA data were found to have a non-normal distribution,
and therefore the nonparametric Kruskal-Wallis test with Dunn’s
post hoc test was used to determine whether there were
statistically significant differences among the different tunnels
and controls. The data from the neurite orientation analysis
(CytoSpectre results) were found to be normally distributed
and thus were analysed by univariate analysis of variance with
Bonferroni’s post hoc test. A p-value less than 0.05 was considered
significant.
RESULTS
Neuronal Network Cultures in Tunnel
Devices
After cell plating, the neurons started to migrate and elongate
neurites into the tunnels. The first neurites and neurons entered
the tunnels as early as 3 days after plating, and typically
by 2–3 weeks the neurons had formed a network covering
approximately the entire area inside the tunnels. Examples
of network growth from the narrowest (w = 100µm) and
widest tunnels (w = 1,500µm) are shown in Figures 3A,B,
respectively. Occasionally, the reversible PDMS-MEA bonding
led to partial detachment of some of the PDMS devices from
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FIGURE 3 | Network development in tunnels and immunocytochemistry images of neuronal cultures. Network development in an h = 43µm, w = 100µm tunnel
(A) and an h = 43µm, w = 1,500µm tunnel (B). The electrode-to-electrode distance is 200µm. Red dashed boxes in (A,B) show the location of the corresponding
subfigures on the right, where somata are indicated by black and neurite bundles by white arrowheads, d, days. Representative MEA traces from the same week are
shown under each tunnel image. The electrodes from which the traces were obtained are marked with white dots. Immunocytochemistry images of two cell lines:
(C) the hiPSC line 04311.WT and (D) the hESC line 08/023 growing on cell culture controls plates. The cell nuclei (DAPI, blue) and neuronal markers
(microtubule-associated protein 2 [MAP2] and class III tubulin [β-tub], green) were stained. (E) Neurite orientation analysis confirmed significantly smaller circular
variances of the networks in tunnels than in freely growing open cultures. nopen culture is 8 and n otherwise is 2–7 (Table 1). Statistical difference between the groups
was analysed using univariate analysis of variance, and the * symbols indicate significance based on Bonferroni’s post hoc test vs. freely growing open cultures (*0.05
> p ≥ 0.01; **0.01 > p ≥ 0.001; ***p > 0.001).
the MEAs. The cultures with insufficient PDMS-MEA bonding
were excluded from the experiments. The neuronal nature of
the used cells was verified by immunocytochemical staining for
known neuronal markers (Figures 3C,D). Cell viability in the
tunnels was good, and no significant cell death or detachment
was observed with phase contrast microscopy during the 5-week
culture period. The tunnels contained neurites and cell somata
migrated into the tunnels. Toward the end of the culture the
neurites tended to form thick bundles that were typically next
to the PDMS walls regardless of the tunnel width. All tunnels
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affected neuronal network development by causing neurite
orientation (Figures 3A,B) compared with random neuronal
networks without tunnels (Figures 3C,D). This observation was
verified by the neurite orientation analysis, which showed that the
mean circular variance values in the networks inside tunnels were
significantly smaller than in freely growing networks [F(3, 31)
= 6.63, p = 0.001; Figure 3E]. The tunnel height had no
significant effect on the neurite orientation [F(1, 31) = 2.94, p =
0.097].The neurites in the narrowest (w = 100µm) tunnels were
the most unidirectional (Figures 3A,E,).
MEA Signal Detection Inside Tunnel
Devices
To determine whether the different tunnel dimensions affected
the signal detection on MEA, we calculated the noise values,
md peak-to-peak signal amplitudes, and from these, the
corresponding SNRs in each active electrode using a custom-
made MATLAB algorithm (Figure 4). Examples of the neuronal
signals are shown in the narrow tunnel (w = 100µm) and wide
tunnel (w= 1,500µm) (Figures 3A,B).
Data from standard 1-well MEAs served as the relevant
control for these parameters because the tunnel device data were
obtained using the same individual MEAs. The 1-well MEA
control data did not contain measurements from the first week
after plating, and week 1 data were therefore omitted from
this analysis but are presented in Supplementary Figure 1. The
outside-group refers to the electrodes outside the tunnels but
under the PDMS lid (Figure 1), and thus have the same h as the
tunnel electrodes.
The md noise values were higher in the electrodes inside
the PDMS tunnels in comparison to the 1-well MEA control
(md 1.3 µV; Figures 4A,B). In the h = 43µm tunnels, noise
was significantly increased in the electrodes inside w = 100µm,
w = 750µm, and w = 1,500µm tunnels (md 1.8, 2.0, and
2.0, p < 0.001; Figure 4A). The 6-well MEA control had a
comparatively high noise level (md 3.1 µV). In the h = 105µm,
the tunnels noise was significantly increased in w = 500µm, w
= 750µm, and w = 1,500µm tunnels (md 1.9, 1.9, and 1.8; p
< 0.001; Figure 4B). In the h = 105µm devices, the noise was
particularly high at the first week after plating (Supplementary
Figure 1), probably due to system stabilization and/or protein
adsorption to the electrode surface. However, inclusion of the
data in the analyses had no significant effect on the results. In
general, noise was significantly higher in the h = 43µm devices
compared with the h = 105µm devices (p < 0.001; Figure 4A
vs. Figure 4B). These results suggest that PDMS tunnels can
increase noise in MEA recordings depending on the tunnel
dimensions.
In agreement with the increased noise values, the md peak-
to-peak signal amplitudes were increased in electrodes inside
tunnel devices when compared with the 1-well MEA control (md
13.3 µV; Figures 4C,D). In the h = 43µm tunnel devices, the
amplitudes were significantly increased in the outside electrodes
as well as the electrodes in w = 100µm, w = 750µm and
w = 1,500µm tunnels (md 18.4, 18.9, 20.1, and 19.5 µV,
respectively; p < 0.001; Figure 4C). The 6-well MEA control
had relatively high signal amplitudes (md 24.3 µV). In the h =
105µm tunnels, the amplitudes were significantly increased in
FIGURE 4 | Noise in active electrodes, signal amplitude and signal-to-noise
ratio. The noise was calculated for active electrodes in h = 43µm (A) and h =
105µm tunnel devices (B) and controls (6 and 1-well MEAs). The tunnel width
or control group is indicated on the x-axes. The median signal amplitude in
active electrodes in h = 43µm (C) and h = 105µm devices (D) and controls
was also calculated. The signal-to-noise-ratio (SNR) in h = 43µm (E) and h =
105µm devices (F) was calculated from the noise and median signal
amplitude in active electrodes. n (active electrodes) is 61–547 (weekly
numbers of active electrodes are in Table 1). Please note that the low number
of h = 43µm, w = 500µm tunnels (2) may affect the results. Statistical
differences between groups were analysed using the Kruskal-Wallis test, and
the * symbols indicate significant differences using Dunn’s post hoc test vs. the
1-well control (*0.05 > p ≥ 0.01; **0.01 > p ≥ 0.001; ***p > 0.001).
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the electrodes in w = 500µm, w = 750µm, and w = 1,500µm
tunnels (md 18.2, 20.0, and 18.0 µV; p < 0.001; Figure 4D).
In general, signal amplitudes were significantly higher in the
electrodes in the h = 43µm devices compared with the h =
105µm devices (p < 0.001; Figure 4C vs. Figure 4D). These
results suggest that PDMS tunnel devices can increase MEA
signal amplitude depending on the device dimensions.
SNR was found to be higher in the electrodes in tunnel devices
compared with the 1-well MEA control (md 8.0, Figures 4E,F).
In the h= 43µm tunnel devices, SNR was significantly increased
in the outside electrodes under the PDMS lid as well as electrodes
in w = 100µm, w = 750µm, and w = 1,500µm tunnels
(md 10.0, 9.9, 9.1, and 9.9, respectively; p < 0.001; Figure 4E).
SNR was lowest in the 6-well MEA controls (md 7.7). In the
h = 105µm tunnel devices, SNR was significantly increased
in the outside electrodes as well as electrodes in w = 100µm,
w = 500µm, w = 750µm, and w = 1,500µm tunnels (md
9.7, 9.8, 9.6, 10.1, and 9.7, respectively; p < 0.001; Figure 4F).
The tunnel height had no significant effect on SNR (p = 0.244;
Figure 4E vs. Figure 4F). In summary, the SNRs recorded from
inside the tunnel devices were very similar, thus making the
differences in noise and signal amplitudes between different
designs irrelevant in terms of MEA signal detection. However,
it appears that a PDMS tunnel device on the MEA in general
improves SNR.
Tunnel Devices Increase Spike and Burst
Activity on MEA
To assess whether the tunnel devices could affect the spike and
burst activity on MEA, we analysed the percentage of active
electrodes, spike count and burst count in active electrodes
using our custom-made MATLAB algorithm (Figure 5). We
compared the activity data from tunnel electrodes to the 6-well
MEA control. The statistical analyses between the tunnel devices
and controls were performed separately each week because the
activity in the tunnel electrodes increased dramatically over time.
The percentage of active electrodes increased in the tunnel
devices (Figures 5A,B). At week 1, the percentage of active
electrodes was highest in the 6-well MEA controls. However,
while the percentage in the 6-well MEA controls decreased
from 46 to 27% over 5 weeks, the percentage in the tunnel
devices steadily increased, surpassing the 6-well MEA controls
2–4 weeks after plating and finally reaching 52–100% at week
5. The percentage of active electrodes was especially high in the
w = 100µm and w = 500µm tunnels, reaching 80–100% by
week 5. The percentages were also higher in the h = 43µm
tunnels compared with the h = 105µm tunnels (69–100%
vs. 52–85% at week 5; Figure 5A vs. Figure 5B). The smallest
tunnels (h = 43µm, w = 100µm) were best in terms of the
percentage of active electrodes, reaching 100% as early as week 3
(Figure 5A).
There were significantly more spikes per active electrode in
the tunnel devices compared with the 6-well MEA controls
(Figures 5C,D). The md spike count in the 6-well MEA controls
never reached higher than 125 over 10min (week 4). The md
spike count was highest, with 3,449 spikes over 10min, in the
smallest tunnels (h = 43µm, w = 100µm) at week 5 (p < 0.001;
Figure 5C). The outside electrodes in the h = 43µm tunnel
devices also had high spike counts, with md reaching 2,715 at
week 5. The spike counts between the outside electrodes and
the w = 100µm tunnels did not differ significantly during any
week. The spike counts were also significantly increased in higher
(h = 105µm) devices compared with the 6-well MEA controls
(Figure 5D). The maximal spike count in the h= 105µmdevices
was reached at week 4, when the md spike count in the w
= 500µm tunnels was 992 (p < 0.001). The md spike count was
nearly as high in the w = 100µm tunnels for the corresponding
time point (964). In general, the spike count was higher in the h
= 43µm tunnel devices compared with the h = 105µm devices.
For example, in the w = 100µm tunnels, the difference was
significant at weeks 4 (2,886 and 964, respectively; p = 0.013)
and 5 (3,449 vs. 907, respectively; p = 0.002; Figure 5C vs.
Figure 5D). Taken together, the spike count data showed that
the w = 100µm tunnels and outside area of the h = 43µm
tunnel devices were the best to increase the amount of measured
network activity.
As with the spike counts, the burst counts were also increased
in the tunnel devices compared with the 6-well MEA controls.
In the 6-well MEA controls, the md burst count was highest at
week 5, with 6 bursts over 10min (Figures 5E,F). In the smallest
tunnels (h = 43µm, w = 100µm), the burst count reached a
maximum, 373, at week 4 (p < 0.001; Figure 5E). The burst
counts were also very high in the outside electrodes of the h =
43µm tunnel devices, with 250 bursts at week 5 (p < 0.001).
The burst counts between the outside electrodes and the w =
100µm tunnels did not differ significantly during any week. The
burst counts were also significantly increased in the higher (h
= 105µm) tunnels compared with the 6-well MEA controls,
achieving a maximum of 108 at week 4 in the w = 500µm
tunnels (p < 0.001; Figure 5F). The md burst count was also
high in the w = 100µm tunnels at the same week, with 80
bursts. However, the number of bursts in the h= 105µm tunnels
was generally less than in the h = 43µm tunnels. For example,
in the w = 100µm tunnels, the difference was significant at
weeks 4 (80 and 373, respectively; p = 0.006) and 5 (56 and
368, respectively; p = 0.002; Figure 5E vs. Figure 5F). The burst
count data suggested that the MEA activity was highest in w =
100-µm-wide tunnels and the outside area of the h = 43-µm-
high tunnel devices, which is consistent with the spike count
results (Figures 5C,D). However, considering also the percentage
of active electrodes (Figures 5A,B), it is not the area outside the
tunnels, but particularly the smallest tunnels (h = 43µm, w =
100µm), that had the greatest ability to increase the amount of
measured network activity.
MEA Activity Inside Tunnel Devices Can Be
Affected by Pharmacological Treatment
To test whether the MEA signals inside the tunnel devices
originated from neuronal activity, we measured the MEA
activity inside the devices before and after TTX treatment
(Figures 6A,B). TTX inhibits the function of neuronal voltage-
gated sodium channels and, therefore, blocks the electrical
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FIGURE 5 | Percentage of active electrodes, spike count and burst count. The percentage of active electrodes was calculated from the MEA data for the h = 43µm
(A) and h=105µm tunnel devices (B) as well as the controls (6 and 1-well MEAs). Total n of analysed electrodes was 23-270 (Table 1). The spike count in the active
electrodes over 10min was also analysed for the h = 43µm (C) and h = 105µm tunnel devices (D) and controls. The number of bursts over 10min was analysed
from the spike data for the h = 43µm (E) and h = 105-µm-high tunnel devices (F) and the controls. n (active electrodes) was 1-167 (Table 1). Please note that the
low number of h = 43µm, w = 500µm tunnels (2) may affect the results. Statistical differences between groups each week were analysed using the Kruskal-Wallis
test, and * symbols indicate significant differences using Dunn’s post hoc test vs. the 6-well control (*0.05 > p ≥ 0.01; **0.01 > p ≥ 0.001; ***p > 0.001).
activity of neurons. After addition of regular medium, the
percentage of active electrodes was between 26% (h = 105µm,
outside electrodes) and 94% (h = 43µm, w = 100µm). After
the addition of TTX to the medium, the percentage of active
electrodes dropped between 5% (h = 105µm, w = 1,500µm)
and 0% (e.g., h = 43µm, w = 100µm). The effect of TTX
on MEA activity in tunnel devices was prompt and clear,
showing that the measured activity was of neuronal origin
and that the tunnel devices can be used in pharmacological
experiments.
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FIGURE 6 | Percentage of active electrodes before and during TTX.
Percentage of active electrodes in h = 43µm (A) and h = 105µm tunnel
devices (B) during 5-min recordings after changing the medium and adding
TTX. Total n of analysed electrodes was 16–180 (Table 1).
DISCUSSION
The aim of this study was to develop novel tunnel devices
that would facilitate and enhance the detection and analysis
of extracellular electrical signals recorded from hPSC-derived
neuronal networks. Neurons were cultured on MEAs covered
by PDMS tunnel devices with varying dimensions, and the
spontaneous electrical activity was measured for 5 weeks. The
tunnels induced unidirectional growth of neurites, and the
neuronal networks filled the tunnels in 2–3 weeks. The PDMS
tunnel devices in general improved SNR, although none of the
tested tunnel devices improved the MEA signal detection more
than others. The tunnel devices increased network activity, and
the smallest tunnels (h = 43µm, w = 100µm) were the best
ones in this regard. The neuronal activity inside the tunnels was
affected by TTX treatment.
Previously, tunnel devices on MEAs have been studied using
rodent derived networks (Goyal and Nam, 2011), but the current
setup is, to the best of our knowledge, the first to test the
compatibility of PDMS tunnels with neuronal networks of
human origin. Cells were plated to both ends of the tunnels, and
this ensured neurite growth and cell migration into the tunnels.
The hPSC-derived networks remained viable and active for the
entire 5-week follow-up period, and we did not observe viability
problems that could result from too small medium volume
or flow inside the tunnels. The tunnels induced unidirectional
growth of neurites, in contrast to the random orientation in
freely growing cultures. Interestingly, similar tunnels in the
study of Goyal and Nam (2011) appeared to instead induce
more random neurite orientation and to increase branching of
rat primary hippocampal neurons. This difference may reflect
both the developmental stage of the neurons and their region-
specific morphology (Dotti et al., 1988). It is also possible that
there is some selectivity in the tunnels for axons over dendrites,
which can explain some of the observed neurite orientation.
However, the tunnels did not exclude dendrites because plenty
of cell somas, from which dendrites branch off, migrated into
the tunnels. The two cell populations attracting each other from
the opposite ends of the tunnel probably also cause the neurites
to grow in a more oriented manner. Overall, the results suggest
that hPSC-derived neuronal networks are compatible with PDMS
tunnel devices on MEA.
In this study, we aimed to improve the detection of electrical
activity from human stem cell-derived neuronal networks on
MEA using tunnel devices. A generally accepted theory in the
field states that signal amplitudes measured by MEA in tunnels
are influenced by a derivative of Ohm’s law, where the resistance
of the medium inside the tunnel increases as the tunnels cross
section (h andw) decreases and length increases (FitzGerald et al.,
2008, 2009; Wang et al., 2012). The increased resistance, in turn,
manifests as higher potential differences during electrical activity
of the measured cells, i.e., higher signal amplitudes measured by
theMEA.However, apart for the slightly higher signal amplitudes
in the h = 43µm in comparison to the h = 105µm tunnels,
there was no clear connection between tunnel the cross section
(h and w) and the signal amplitudes. Additionally, earlier studies
examining tunnel devices have reported significant, considerably
larger increases in noise and signal amplitudes when measuring
rodent neurons (Morales et al., 2008; Dworak and Wheeler,
2009; FitzGerald et al., 2009; Goyal and Nam, 2011; Habibey
et al., 2015). The w and h of our smallest tunnels (w = 100µm,
h = 43µm) were most similar to the tunnels described by Goyal
and Nam (w = 50 or 100µm, h = 50µm) (Goyal and Nam
2011), who obtained spike amplitudes of several hundred µV,
considerably higher than in our tunnels. This difference is most
likely due to different tunnel lengths, since the length of the
tunnels described by Goyal and Nam was 7-fold compared with
our tunnels, and such an increase in the tunnel length has been
shown to amplify the signal significantly (FitzGerald et al., 2008,
2009). However, in terms of signal detection, it is most useful to
study the ratio between the noise and signal amplitude (SNR).
Here, SNR in any of the tested tunnels did not increase more
than 1.3-fold, reaching a value of 10. Although the increase was
statistically significant, the median SNRs were rather modest
in comparison to those reported earlier for the much smaller,
axon-encompassing microtunnels, where SNR has reached as
high as 80 (Wang et al., 2012) or even 450 (Pan et al., 2014)
depending on the tunnel dimensions. Furthermore, the SNR in
the current study did not depend on tunnel dimensions. Thus,
it seems likely that the slight improvement in SNR occurred
because the PDMS device guided the neurons to grow on or
near the electrodes, and shortened the distance between the signal
source and detector (Obien et al., 2015). It is also possible that the
cleaning procedures between the experiments have affected the
signal detection properties of the MEAs. All and all, the results
concur with earlier simulation studies and the general theory in
the field (FitzGerald et al., 2008, 2009; Wang et al., 2012), which
suggest that the current, comparatively high and wide, but short,
tunnels do not provide high enough resistance to improve signal
detection on MEA.
Although the tested PDMS tunnel devices had nomajor effects
on SNR, we found that the tunnel devices dramatically increased
the percentage of active electrodes and the amount of detected
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spike and burst activity on those electrodes when measuring
hPSC-derived neuronal networks. Despite the advantages and
potential of hPSC-derived networks in in vitro modelling
(Hunsberger et al., 2015), they can be very slow (Odawara et al.,
2016) and unpredictable in developing neuronal activity, and
the low percentage of activity-detecting electrodes can especially
complicate MEA data acquisition and analysis (Ylä-Outinen
et al., 2010; Tukker et al., 2016). In our setup, the smallest of
the tested tunnels were able to increase the portion of active
electrodes up to 100% in only 3 weeks, increasing spike activity
12-fold and burst activity 30-fold at the same time. It is possible
that the observed activity increases because the electrodes in
the tunnels observe the same signal from multiple sites of the
same neuron or network. However, in this case the signals
in the tunnel electrodes would appear synchronous, and we
observed synchronous activity only occasionally (spanning to
two or three adjacent electrodes), while majority of the activity
was non-synchronous. Increasing spike activity and temporal
clustering of spikes into bursts are generally considered as signs
of network activity maturation (Kapucu et al., 2012; Biffi et al.,
2013; Odawara et al., 2016). It is possible that the maturation
here was accelerated because the tunnels increased the density of
neurons by limiting the area on which they can grow. However,
according to earlier results from primary rodent cultures, simply
increasing cell density cannot make the percentage of active
electrodes exceed 60%, and once the maximum has been reached,
increasing cell density merely decreases activity (Biffi et al.,
2013). According to our own experience the maximum of active
electrodes in hPSC-derived cultures is ∼50%. This suggest that
some additional feature of the smallest tunnels, such as the effect
on neurite orientation or efficient placing of the network on
the electrodes, can significantly increase the detected network
activity.
Not only the smallest but also larger tunnels significantly
increased the amount of detected activity in comparison to
control MEAs, and in particular the electrodes outside the
actual tunnels but under the PDMS lid detected very high
spike and burst activity. This finding implies that either the
outer walls of the tunnels (at a right angle to the tunnel
itself, Figure 1) function as guiding barriers that localize the
developing networks on the outside electrodes, or that the
tunnels funnel the networks from the outside area (Figure 3A),
or both. However, we cannot exclude the possibility that the
increase in detected activity reflects an increase in sensitivity
of the system because the extracellular signals are detected
when they cross a threshold, which depends on the noise level.
This phenomenon could explain the increased activity in the
h = 43µm devices in comparison to the h = 105µm devices.
Besides changes in measurement sensitivity, the differences in
results between the tunnel heights can be influenced by the
batch-to-batch variation of hPSCs. Still, the increased activity
inside the tunnels followed the observed growth of the neuronal
network, and differences in activity between the controls and
PDMS device electrodes increased over time, indicating a
facilitation of network activity development. The results suggest
that PDMS tunnel devices are a valuable tool for increasing
the measurable activity on MEA and can therefore save time
and money when using hPSC-derived neurons in disease
modelling, pharmacological testing or toxicological screening
in vitro.
If tunnel devices are to be used for in vitro modelling, the
activity inside the tunnels must be amenable to pharmacological
manipulation. To date, reports from pharmacological
experiments in tunnel devices are lacking, except one (Dworak
and Wheeler, 2009). Here, we evaluated the effects of a well-
established blocker of neuronal activity (TTX) on the MEA
signals from entire neuronal networks inside PDMS tunnels.
The MEA measurements were performed directly after addition
of TTX to the medium, and the results showed that the
pharmacological effect of a neuron-specific toxicant inside the
tunnels was clear and manifested immediately.
We conclude that PDMS tunnel devices on MEAs are
a suitable environment for cultivating neuronal networks of
human origin. Although the effects of the tunnel devices on SNR
were modest, the devices substantially increased the percentage
of active electrodes and amount of detected neuronal network
activity in a design-dependent and robust fashion. The tunnels
are also suitable for pharmacological testing. Therefore, PDMS
tunnel devices encompassing neuronal networks are a promising
tool for reducing time and costs in analyses of the activity of
hPSC-derived neuronal models on MEAs.
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